182 related articles for article (PubMed ID: 29234687)
1. Delivery of CR2-fH Using AAV Vector Therapy as Treatment Strategy in the Mouse Model of Choroidal Neovascularization.
Schnabolk G; Parsons N; Obert E; Annamalai B; Nasarre C; Tomlinson S; Lewin AS; Rohrer B
Mol Ther Methods Clin Dev; 2018 Jun; 9():1-11. PubMed ID: 29234687
[TBL] [Abstract][Full Text] [Related]
2. Regulatable Complement Inhibition of the Alternative Pathway Mitigates Wet Age-Related Macular Degeneration Pathology in a Mouse Model.
Parsons NB; Annamalai B; Rohrer B
Transl Vis Sci Technol; 2023 Jul; 12(7):17. PubMed ID: 37462980
[TBL] [Abstract][Full Text] [Related]
3. Subretinal Rather Than Intravitreal Adeno-Associated Virus-Mediated Delivery of a Complement Alternative Pathway Inhibitor Is Effective in a Mouse Model of RPE Damage.
Annamalai B; Parsons N; Nicholson C; Obert E; Jones B; Rohrer B
Invest Ophthalmol Vis Sci; 2021 Apr; 62(4):11. PubMed ID: 33830174
[TBL] [Abstract][Full Text] [Related]
4. Encapsulated Cell Technology-Based Delivery of a Complement Inhibitor Reduces Choroidal Neovascularization in a Mouse Model.
Annamalai B; Parsons N; Belhaj M; Brandon C; Potts J; Rohrer B
Transl Vis Sci Technol; 2018 Mar; 7(2):3. PubMed ID: 29576927
[TBL] [Abstract][Full Text] [Related]
5. A targeted inhibitor of the alternative complement pathway reduces angiogenesis in a mouse model of age-related macular degeneration.
Rohrer B; Long Q; Coughlin B; Wilson RB; Huang Y; Qiao F; Tang PH; Kunchithapautham K; Gilkeson GS; Tomlinson S
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3056-64. PubMed ID: 19264882
[TBL] [Abstract][Full Text] [Related]
6. The use of Matrigel combined with encapsulated cell technology to deliver a complement inhibitor in a mouse model of choroidal neovascularization.
Annamalai B; Parsons N; Brandon C; Rohrer B
Mol Vis; 2020; 26():370-377. PubMed ID: 32476817
[TBL] [Abstract][Full Text] [Related]
7. Systemic human CR2-targeted complement alternative pathway inhibitor ameliorates mouse laser-induced choroidal neovascularization.
Rohrer B; Coughlin B; Bandyopadhyay M; Holers VM
J Ocul Pharmacol Ther; 2012 Aug; 28(4):402-9. PubMed ID: 22309197
[TBL] [Abstract][Full Text] [Related]
8. Natural immunoglobulin M-based delivery of a complement alternative pathway inhibitor in mouse models of retinal degeneration.
Annamalai B; Parsons N; Nicholson C; Joseph K; Coughlin B; Yang X; Jones BW; Tomlinson S; Rohrer B
Exp Eye Res; 2021 Jun; 207():108583. PubMed ID: 33878326
[TBL] [Abstract][Full Text] [Related]
9. A targeted inhibitor of the complement alternative pathway reduces RPE injury and angiogenesis in models of age-related macular degeneration.
Rohrer B; Long Q; Coughlin B; Renner B; Huang Y; Kunchithapautham K; Ferreira VP; Pangburn MK; Gilkeson GS; Thurman JM; Tomlinson S; Holers VM
Adv Exp Med Biol; 2010; 703():137-49. PubMed ID: 20711712
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the alternative complement pathway accelerates repair processes in the murine model of choroidal neovascularization.
Parsons N; Annamalai B; Obert E; Schnabolk G; Tomlinson S; Rohrer B
Mol Immunol; 2019 Apr; 108():8-12. PubMed ID: 30763805
[TBL] [Abstract][Full Text] [Related]
11. Local production of the alternative pathway component factor B is sufficient to promote laser-induced choroidal neovascularization.
Schnabolk G; Coughlin B; Joseph K; Kunchithapautham K; Bandyopadhyay M; O'Quinn EC; Nowling T; Rohrer B
Invest Ophthalmol Vis Sci; 2015 Jan; 56(3):1850-63. PubMed ID: 25593023
[TBL] [Abstract][Full Text] [Related]
12. New Insights on Complement Inhibitor CD59 in Mouse Laser-Induced Choroidal Neovascularization: Mislocalization After Injury and Targeted Delivery for Protein Replacement.
Schnabolk G; Beon MK; Tomlinson S; Rohrer B
J Ocul Pharmacol Ther; 2017 Jun; 33(5):400-411. PubMed ID: 28333572
[TBL] [Abstract][Full Text] [Related]
13. Cell-specific gene therapy driven by an optimized hypoxia-regulated vector reduces choroidal neovascularization.
Biswal MR; Prentice HM; Smith GW; Zhu P; Tong Y; Dorey CK; Lewin AS; Blanks JC
J Mol Med (Berl); 2018 Oct; 96(10):1107-1118. PubMed ID: 30105447
[TBL] [Abstract][Full Text] [Related]
14. Preliminary in vitro and in vivo assessment of a new targeted inhibitor for choroidal neovascularization in age-related macular degeneration.
Li W; Dong L; Ma M; Hu B; Lu Z; Liu X; Liu J; Li X
Drug Des Devel Ther; 2016; 10():3415-3423. PubMed ID: 27799741
[TBL] [Abstract][Full Text] [Related]
15. Development of gene therapy for treatment of age-related macular degeneration.
Askou AL
Acta Ophthalmol; 2014 Jul; 92 Thesis3():1-38. PubMed ID: 24953666
[TBL] [Abstract][Full Text] [Related]
16. A non membrane-targeted human soluble CD59 attenuates choroidal neovascularization in a model of age related macular degeneration.
Cashman SM; Ramo K; Kumar-Singh R
PLoS One; 2011 Apr; 6(4):e19078. PubMed ID: 21552568
[TBL] [Abstract][Full Text] [Related]
17. A Targeted Inhibitor of the Alternative Complement Pathway Accelerates Recovery From Smoke-Induced Ocular Injury.
Woodell A; Jones BW; Williamson T; Schnabolk G; Tomlinson S; Atkinson C; Rohrer B
Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1728-37. PubMed ID: 27064393
[TBL] [Abstract][Full Text] [Related]
18. Optical coherence tomography of age-related macular degeneration and choroidal neovascularization.
Hee MR; Baumal CR; Puliafito CA; Duker JS; Reichel E; Wilkins JR; Coker JG; Schuman JS; Swanson EA; Fujimoto JG
Ophthalmology; 1996 Aug; 103(8):1260-70. PubMed ID: 8764797
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of FH Protection Against Neovascular AMD.
Borras C; Delaunay K; Slaoui Y; Abache T; Jorieux S; Naud MC; Sanharawi ME; Gelize E; Lassiaz P; An N; Kowalczuk L; Ayassami C; Moulin A; Behar-Cohen F; Mascarelli F; Dinet V
Front Immunol; 2020; 11():443. PubMed ID: 32318056
[TBL] [Abstract][Full Text] [Related]
20. A novel targeted inhibitor of the alternative pathway of complement and its therapeutic application in ischemia/reperfusion injury.
Huang Y; Qiao F; Atkinson C; Holers VM; Tomlinson S
J Immunol; 2008 Dec; 181(11):8068-76. PubMed ID: 19017999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
